Next Article in Journal
Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability
Next Article in Special Issue
A Decade of Antifungal Leads from Natural Products: 2010–2019
Previous Article in Journal
Iron as Therapeutic Target in Human Diseases
Previous Article in Special Issue
Biological Evaluation of Arylsemicarbazone Derivatives as Potential Anticancer Agents
 
 
Meeting Report

Article Versions Notes

Pharmaceuticals 2019, 12(4), 179; https://doi.org/10.3390/ph12040179
Action Date Notes Link
article xml file uploaded 6 December 2019 10:10 CET Original file -
article xml uploaded. 6 December 2019 10:10 CET Update https://www.mdpi.com/1424-8247/12/4/179/xml
article pdf uploaded. 6 December 2019 10:10 CET Version of Record https://www.mdpi.com/1424-8247/12/4/179/pdf
article html file updated 6 December 2019 10:12 CET Original file -
article html file updated 30 December 2019 22:49 CET Update -
article html file updated 14 February 2020 16:25 CET Update https://www.mdpi.com/1424-8247/12/4/179/html
Back to TopTop